Umbilical cord wrap may help men recover faster after prostate cancer surgery

NCT ID NCT04263025

Ongoing Symptom relief Sponsor: Hackensack Meridian Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether placing a cryopreserved umbilical cord allograft around nerves during robotic prostatectomy helps men regain erectile function and bladder control sooner. About 100 men with prostate cancer will be randomly assigned to receive either standard surgery or surgery plus the cord wrap. Researchers will track recovery over 12 months using questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cryopreserved umbilical cord allograft (CLARIX® CORD 1K)
What this could lead to: If it works, this could help men regain sexual and bladder control faster after prostate cancer surgery.
What could go wrong: This is an early-to-mid-stage trial with only 100 participants, so results may not apply to everyone. The allograft is a processed tissue product, and its long-term benefits or risks are not yet fully known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Hackensack University Medical Center

Hackensack, New Jersey, 07601, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.